Shine Hee Lee & Sang-Bum Kang. (2022) Abdominal Pain over 6 Months. The Korean Journal of Medicine 97:6, pages 361-367.
Crossref
Konstantinos Gkikas, Michael Logan, Ben Nichols, Umer Z. Ijaz, Clare M. Clark, Vaios Svolos, Lisa Gervais, Hazel Duncan, Vikki Garrick, Lee Curtis, Elaine Buchanan, Tracey Cardigan, Lawrence Armstrong, Caroline Delahunty, Diana M. Flynn, Andrew R. Barclay, Rachel Tayler, Simon Milling, Richard Hansen, Richard K. Russell & Konstantinos Gerasimidis. (2021) Dietary triggers of gut inflammation following exclusive enteral nutrition in children with Crohn’s disease: a pilot study. BMC Gastroenterology 21:1.
Crossref
Lili Lily Jia, Louise Brough & Janet Louise Weber. (2021) Saccharomyces cerevisiae Yeast-Based Supplementation as a Galactagogue in Breastfeeding Women? A Review of Evidence from Animal and Human Studies. Nutrients 13:3, pages 727.
Crossref
Konstantinos Gkikas, Konstantinos Gerasimidis, Simon Milling, Umer Z. Ijaz, Richard Hansen & Richard K. Russell. (2020) Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?. Nutrients 12:7, pages 2018.
Crossref
Rebecca A Hall & Mairi C Noverr. (2017) Fungal interactions with the human host: exploring the spectrum of symbiosis. Current Opinion in Microbiology 40, pages 58-64.
Crossref
L.V. McFarland. 2017. The Microbiota in Gastrointestinal Pathophysiology. The Microbiota in Gastrointestinal Pathophysiology
145
164
.
I. Ahmed, R. Greenwood, B. Costello, N. Ratcliffe & C. S. Probert. (2016) Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 43:5, pages 596-611.
Crossref
Christel Chehoud, Lindsey G. Albenberg, Colleen Judge, Christian Hoffmann, Stephanie Grunberg, Kyle Bittinger, Robert N. Baldassano, James D. Lewis, Frederic D. Bushman & Gary D. Wu. (2015) Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 21:8, pages 1948-1956.
Crossref
Dale Lee, Lindsey Albenberg, Charlene Compher, Robert Baldassano, David Piccoli, James D. Lewis & Gary D. Wu. (2015) Diet in the Pathogenesis and Treatment of Inflammatory Bowel Diseases. Gastroenterology 148:6, pages 1087-1106.
Crossref
Imran Aziz, Federica Branchi, Katherine Pearson, Josephine Priest & David S. Sanders. (2015) A Study Evaluating the Bidirectional Relationship Between Inflammatory Bowel Disease and Self-reported Non-celiac Gluten Sensitivity. Inflammatory Bowel Diseases 21:4, pages 847-853.
Crossref
Adam M. Berg & Francis A. Farraye. 2014. Medical Therapy of Ulcerative Colitis. Medical Therapy of Ulcerative Colitis
237
250
.
Hiromasa Takaishi, Takanori Kanai, Atsushi Nakazawa, Fumihiko Sugata, Akira Nikai, Shigeo Yoshizawa, Yasuo Hamamoto, Shinsuke Funakoshi, Tomoharu Yajima, Yasushi Iwao, Masao Takemura, Shoichi Ozaki & Toshifumi Hibi. (2012) Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype. Journal of Gastroenterology 47:9, pages 969-977.
Crossref
Leo Galland. 2012. Integrative Medicine. Integrative Medicine
464
474.e5
.
Iris Dotan. 2012. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
277
285
.
May Loo. 2009. Integrative Medicine for Children. Integrative Medicine for Children
379
392
.
Andrew D Butterworth, Adrian G Thomas & Anthony Kwaku Akobeng. (2008) Probiotics for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
Gregor Bartel, Ilse Weiss, Karl Turetschek, Wolfgang Schima, Andreas Püspök, Thomas Waldhoer & Christoph Gasche. (2008) Ingested matter affects intestinal lesions in Crohnʼs disease. Inflammatory Bowel Diseases 14:3, pages 374-382.
Crossref
Hakan Cinemre, Cemil Bilir, Feyzi Gokosmanoglu & Figen Kadakal. (2023) Anti-Saccharomyces cerevisiae Antibodies in Acute Myocardial Infarction. Journal of Investigative Medicine 55:8, pages 444-449.
Crossref
Leo Galland. 2007. Integrative Medicine. Integrative Medicine
541
554
.
Brigitt Brunner, Ulrich Scheurer & Frank Seibold. (2007) Differences in Yeast Intolerance Between Patients with Crohn's Disease and Ulcerative Colitis. Diseases of the Colon & Rectum 50:1, pages 83-88.
Crossref
Dieter Genser. 2007. Psychosomatik in der Gastroenterologie und Hepatologie. Psychosomatik in der Gastroenterologie und Hepatologie
165
182
.
W. H. Kim & S. K. Lee. 2007. Emerging Issues in Inflammatory Bowel Diseases. Emerging Issues in Inflammatory Bowel Diseases
46
58
.
Chang Hwan Choi, Tae Il Kim, Byung Chang Kim, Sung Jae Shin, Sang Kil Lee, Won Ho Kim & Hyon Suk Kim. (2006) Anti- Saccharomyces cerevisiae Antibody in Intestinal Behçet's Disease Patients: Relation to Clinical Course. Diseases of the Colon & Rectum 49:12, pages 1849-1859.
Crossref
Vivien E Rolfe, Paul J Fortun, Christopher J Hawkey & Fiona J Bath-Hextall. (2006) Probiotics for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Annie Standaert–Vitse, Thierry Jouault, Peggy Vandewalle, Céline Mille, Mimouna Seddik, Boualem Sendid, Jean–Maurice Mallet, Jean–Frédéric Colombel & Daniel Poulain. (2006) Candida albicans Is an Immunogen for Anti–Saccharomyces cerevisiae Antibody Markers of Crohn’s Disease. Gastroenterology 130:6, pages 1764-1775.
Crossref
Martin H. Floch & David C. Montrose. (2005) Use of Probiotics in Humans: An Analysis of the Literature. Gastroenterology Clinics of North America 34:3, pages 547-570.
Crossref
David C Montrose & Martin H Floch. (2005) Probiotics Used in Human Studies. Journal of Clinical Gastroenterology 39:6, pages 469-484.
Crossref
Heiko Santelmann & John McLaren Howard. (2005) Yeast metabolic products, yeast antigens and yeasts as possible triggers for irritable bowel syndrome. European Journal of Gastroenterology & Hepatology 17:1, pages 21-26.
Crossref
Lori Kam & Eric A. Vasiliauskas. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
409
429
.
Anders Ekbom & Scott M Montgomery. (2004) Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Practice & Research Clinical Gastroenterology 18:3, pages 497-508.
Crossref
Nobuhide Oshitani, Fumihiko Hato, Seiichi Kitagawa, Kenji Watanabe, Yasuhiro Fujiwara, Kazuhide Higuchi, Takayuki Matsumoto & Tetsuo Arakawa. (2003)
Distinct Elevation of Levels of Anti-
Caenorhabditis elegans
Antibody in Sera of Patients with Inflammatory Bowel Disease
. Clinical and Vaccine Immunology 10:5, pages 856-861.
Crossref
Nobuhide Oshitani1, Fumihiko Hato, Kenichi Suzuki, Yoshinori Sawa, Takayuki Matsumoto, Kiyoshi Maeda, Kazuhide Higuchi, Seiichi Kitagawa & Tetsuo Arakawa. (2003) Cross-reactivity of yeast antigens in human colon and peripheral leukocytes. The Journal of Pathology 199:3, pages 361-367.
Crossref
Zsolt Barta. (2003)
Seroreactivity against
Saccharomyces cerevisiae
in patients with Crohn’s disease and celiac disease
. World Journal of Gastroenterology 9:10, pages 2308.
Crossref
Lori Kam & Eric A. Vasiliauskas. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
409
429
.
J. Van Den Bogaerde, J. Cahill, A. V. Emmanuel, C. J. Vaizey, I. C. Talbot, S. C. Knight & M. A. Kamm. (2002) Gut mucosal response to food antigens in Crohn's disease. Alimentary Pharmacology & Therapeutics 16:11, pages 1903-1915.
Crossref
Aaron Lerner & Yehuda Shoenfeld. (2002) Serological markers in inflammatory bowel disease: the pros and cons. European Journal of Gastroenterology & Hepatology 14:2, pages 103-105.
Crossref
J. Van Den Bogaerde, M. A. Kamm & S. C. Knight. (2008) Immune sensitization to food, yeast and bacteria in Crohn’s disease. Alimentary Pharmacology & Therapeutics 15:10, pages 1647-1653.
Crossref
William Y Chey, Ayub Hussain, Charlotte Ryan, Gregory D Potter & Ashok Shah. (2001) Infliximab for refractory ulcerative colitis. American Journal of Gastroenterology 96:8, pages 2373-2381.
Crossref
N. Oshitani, F. Hato, Y. Jinno, Y. Sawa, S. Nakamura, T. Matsumoto, S. Seki, S. Kitagawa & T. Arakawa. (2001)
IgG subclasses of anti
Saccharomyces cerevisiae
antibody in inflammatory bowel disease
. European Journal of Clinical Investigation 31:3, pages 221-225.
Crossref
Nobuhide Oshitani, Kazuhide Higuchi, Takayuki Matsumoto & Tetsuo Arakawa. 2001. Trends in Gastroenterology and Hepatology. Trends in Gastroenterology and Hepatology
205
207
.
S. C. Bischoff. 2001. Chronisch entzündliche Darmerkrankungen. Chronisch entzündliche Darmerkrankungen
171
177
.
Nobuhibe Oshitani, Fumihiko Hato, Takayuki Matsumoto, Yoshio Jinno, Yoshinori Sawa, Junichi Hara, Shiro Nakamura, Shuichi Seki, Tetsuo Arakawa, Atsuo Kitano, Seiichi Kitagawa & Tetsuo Kuroki. (2000)
Decreased anti-S
accharomyces cerevisiae
antibody titer by mesalazine in patients with Crohn’s disease
. Journal of Gastroenterology and Hepatology 15:12, pages 1400-1403.
Crossref
M. Robinson. 2000. Trends in Inflammatory Bowel Disease Therapy 1999. Trends in Inflammatory Bowel Disease Therapy 1999
73
86
.
Mihailo Alic. (1999) Baker's Yeast in Crohn's Disease—Can It Kill You?. American Journal of Gastroenterology 94:6, pages 1711.
Crossref
C. J. Darroch, R. M. Barnes & J. Dawson. (1999) Circulating antibodies to Saccharomyces cerevisiae (bakers'/brewers' yeast) in gastrointestinal disease. Journal of Clinical Pathology 52:1, pages 47-53.
Crossref
Simon H. Murch & John A. Walker-Smith. (1998) 5 Nutrition in inflammatory bowel disease. Baillière's Clinical Gastroenterology 12:4, pages 719-738.
Crossref
B SendidJ F ColombelP M JacquinotC FailleJ FruitA CortotD LucidarmeD CamusD Poulain. (1996) Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clinical Diagnostic Laboratory Immunology 3:2, pages 219-226.
Crossref
Peter R. Gibson. (2012) Inflammatory Bowel Disease. Clinical Immunotherapeutics 2:2, pages 134-160.
Crossref
Thomas T. Macdonald & Simon H. Murch. (1994) Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillière's Clinical Gastroenterology 8:1, pages 1-34.
Crossref